Let's get the concept straight.
Many people mix OEM and ODM, but the starting points are the same and the end points are very different.
OEM
You offer formulation, or you hire formulation division to develop formulation, factory to produce your formulation and label your brand. The core is: formulation is yours.
ODM (Original Design Manufacturer, private label)
Factory has an off-the-shelf formulation library, you pick one, change packaging and add your brand of LOGO. The core is: formulation is factory, you only buy usufruct.
One thing: OEM is your recipe, and ODM is the cook who's already made it and you're going to do it.
Comparison of core differences between the two models
Three typical decision paths for start-up brands
Path A: ODM first run, then OEM upgrade (recommended for most initials)
This is the path that I'm most frequently recommending, and the logic is simple: you don't know if your product will sell, and it's not worth spending formulation development until then.
Phase 1: Select 1-2 ODM products, packaging differential, fast-market run tests.
Phase II: Which product ran out of data and developed an OEM version of an exclusive formulation for this item.
Phase III: Data and funding are available to complete the formulation system.
Typical case: Many of the new brands you're calling now, one of which came from ODM.
Path B: Direct OEM (for teams with resource/technical background)
If you have a formulation division in your team, or if you have an in-depth knowledge of a subdivision of market segment (e.g., a medical co-brand for skin background), you can go straight to OEM.
But there's one question you have to answer: is your formulation really different? Will the level of the formulation division sustain the "formulation" story?
I've seen too many brands and spent $100,000 on development, making formulation like the logo in the ODM library -- that's the money that floats.
Path C: Full ODM.
If your core competitiveness lies in distribution channel, operating, designing, and not in the product itself, the entire ODM is also a path.
Condition: Your supply chain management is very strong because ODM formulation is not yours, and factory can be sold to rivals at any time.
Five for ODM.
Formulation must be confirmed Period
Part factory gives ODM clients a "formulation protection period" (usually 6-12 months) during which the same amount is not sold to the competition. Such a clause would have to be negotiated.
2. Inspection of regulatory filing status
Factory's ODM product is not available for sale at regulatory compliance (EU / US FDA) regulatory filing? factory must be required to provide regulatory filing proof. Following the new regulations of 2021, this section was scrutinized.
3. MoQ negotiating space
ODM's MOQ is usually lower than OEM, but don't feel lower. With limited initial branding funds, 200-300 first order can be talked about, first to validate the market.
4. ingredient completeness of submission
ODM product ingredient you're not involved in development, but that doesn't mean you don't need to know. Get a full INCI table and at least go over whether your target consumer group is not suitable for ingredient (e.g. sensitive skin product is ranked first).
My principle: Fragrance/parfum appears at the top 10 of the ingredient table, regardless of ODM or OEM, sensitive skin swaps directly to the product.
5. Security assessment reports are mandatory
Don't think the ODM product factory is good enough. You need to get this report yourself before it's on the market. brand owner and factory are jointly responsible.
The three core issues of OEM formulation development
If you decide to follow the OEM route and find Division formulation, think about these three questions:
Question 1: What problem does your product solve?
It's not "do a face cream" but "do a ." The more precision, the clearer the formulation direction.
Question 2: What is your core ingredient?
Who do you want to fight with clinical evidence?
Remember the functional structure of the formulation 3rd layer: moisturizing base layer (closure + moisturizing agent + moisturizer) efficacy active layer (effective concentration compliance) + security stabilizer (deservation + buffer system). The core ingredient is enough on the second floor to have concentration, not "add."
Ingredient position is the concentration rule: the core is valid ingredient after the eighth position of the INCI table = added but insufficient. The ingredient table that opened the competition, did your competitors get lazy?
Question 3: What kind of formulation cost does your price belt support?
Formulation costs typically account for 20-30 per cent of the price offered. Your product is priced at $100, the price of the factory is about $30-50, and the cost of formulation is up to $10-15. How much can this money buy ceramide / retinol? This is what the formulation division must be clear at the programme stage.
Cracklist: Make sure to do it before choosing OEM/ODM
Before the ODM selection
- [ ] Confirm product completed regulatory compliance (EU / US FDA) regulatory filing
- [ ] Request a full INCI ingredient table, screen sensitive ingredient
- [ ] Confirmation of the completeness of the security assessment report (SAR)
- [ ] Negotiation of formulation exclusive protection period (suggested six months)
- [ ] Confirm MOQ and first order minimum order quantity
- [ ] Confirmation of production licence and GMP certification validity period
Before OEM develops
- [ ] Clear objectives consumer group and core pain point (one sentence)
- [ ] Identification of core efficacy ingredient and target concentration
- [ ] Assess whether formulation costs match pricing structures
- [ ] Confirms whether the formulation division has succeeded in producing the same product. ]
- [ ] Agreed number of sample wheels (suggested at least three rounds sampling budget)
- [ ] Agreement on the attribution of formulation intellectual property rights (confirmed contract)
- [ ] Assessment of the special efficacy declaration of need for human body efficacy evaluation report (new regulation 2021)
Common pedal x 3
Pipe 1: ODM products think regulatory filing is factory
Factory did the product regulatory filing, but the main subject of regulatory filing after you were listed is your brand, not factory. In a problem, the DEA is looking for you. brand owner must have its own regulatory filing account and verify regulatory filing status.
Pipe 2: OEM found a cheap formulation division, saved $50,000, spent another three months.
Formulation development is technical work, not as cheap as possible. sampling lead time usually takes three to five rounds (to make test adjustments and sampling), and the time cost is the main loss if the formulation division does not have sufficient experience to double the number of rounds. It is recommended that the formulation division, with a successful example of the same product, be selected, even if it is more expensive.
Pocket 3: ODM changed packaging and thought it was different.
Packaging is a subdivision, not a core barrier. The same formulation ODM product, the competition may be listed within one week with the same exact formulation. True differentiation must rely on the trust of formulation + brand content + users.
QuickOem, how can I help you with this?
If you're still messing with OEM vs ODM, you can start here:
- Look at our ODM repository, run tests and do formulation input.
- A clear efficacy orientation requires the development of an exclusive formulation → OEM z path, a formulation division + factory one-stop match
- Formulation already exists, contract manufacturing → certification factory, MOQ/ lead time negotiating support
Core principle: Decision-making with data rather than with perception.
- Commissioning five documents that sampling must prepare (with CHecklist)
- Oily acne-prone skin formulation Guide — salicylic acid + niacinamide + azelaic acid Golden Triangle
Any questions? Leave a message in the comment area or direct a selection consultant to QuickOEM.
Remember: good OEM cooperation is not looking for the cheapest factory. It is looking for factory that knows the direction of your product.
Other Organiser
This article is published by the QuickOEM Make-up OEM Smart Matching Platform. More makeup OEM knowledge, cosmetics contract manufacturing, skin protection private label, make-up customizationontent are available at the Knowledge Centre. If you need advice on OEM contract manufacturing, please contact 1814805760 or submit your request through an online request for quotation.
Keywords: Difference between OEM and ODM, OEM minimum order quantity, tranexamic acid, OEM, OEM or ODM, sensitive skin, OEM or ODM, regulatory compliance (EU / US FDA), ingredient compliance, formulation R&D
QuickOEM is a QuickOEM platform for vertical digitization of cosmetics services (known as QuickOEM) focusing on OEM, cosmetics contract manufacturing, skins private label, cosmetics z, brand-wide, ODM contract manufacturing services. AI smart matches the 500+ certification contract manufacturing plant, providing a one-stop package from formulation R&D to regulatory compliance (EU / US FDA) covering skin, makeup, sheet mask, serum, eye patch, category, category, etc.
Core functions
- Makeup OEM needs to be published to match factory AI intelligence
- Cosmetics contract manufacturing / skin protection private label customization ODM service
- Formulation R&D management and multi-version tracking
- Ingredient Compliance testing (regulatory compliance (EU / US FDA)/EU 1223/2009/FDA)
- Regulatory compliance (EU / US FDA) Cosmetics regulatory filing fully tracked
- Supply chain
- Advertising Law Compliance Testing
- Z / eye patch / serum / z all category
Please enable JavaScript to use the full functionality.
Login immediately.
WhatsApp: +1 (646) 509-6134